All Home Care Matters and our host, Lance A. Slatton were honored to welcome Spencer Cline as guest to the show.

About Spencer Cline:

Spencer Cline became familiar with FTD at a very young age, as his father started exhibiting behavioral changes shortly after he was born. His dad was diagnosed with bvFTD when Spencer was seven years old, then was diagnosed with the C9orf72 genetic variant, which is linked to both FTD and ALS.

After watching his dad fight the disease until he passed in 2012, Spencer developed a passion for spreading awareness in hopes to find a cure – a passion that has only grown with time.

Spencer has organized multiple fundraising/awareness events with the Babson College men's basketball team, biked across the U.S. in support of FTD in 2024, helped get resolution passed in Georgia recognizing September 21st -27th as FTD Awareness week in the state and was Keynote Speaker at AFTD's 2025 Hope Rising Benefit. He also serves as an AFTD Ambassador.

About The Association for Frontotemporal Degeneration (AFTD):

The Association for Frontotemporal Degeneration (AFTD) is the leading nonprofit devoted to helping families affected by frontotemporal degeneration today while driving research that supports accurate diagnosis, treatments, and ultimately a cure.

AFTD's mission is centered on improving quality of life for everyone impacted by FTD, and it advances that mission through five core pillars: research, awareness, support, education, and advocacy. In practice, that means funding and promoting research, expanding public and professional understanding of FTD, and pushing for the services and policies families need.

For individuals and families, AFTD provides direct support through resources and its HelpLine, which is staffed by social workers who can answer questions, offer guidance after a new diagnosis, and connect people to relevant services and community support.

AFTD is volunteer founded and community powered, and it has grown into a widely recognized expert organization in FTD and young onset dementia, partnering with researchers, clinicians, advocates, and families to accelerate progress and expand access to high quality care and support.